Eslicarbazepine is a novel adds on therapy introduced in Indian market in April 2011 in the management of partial seizures. Despite of having a strong pool of evidences & EMEA approval, this molecule in-clinic usage is not as per expectations. Through this research work, we intend to make an attempt to understand underlying psychological & environmental (peer group effect) factors restricting the potential of molecule. The major emphasize of my work was to "EVALUATION OF IN - CLINIC USAGE OF ESLICARBAZEPINE IN THE MANAGEMENT OF PARTIAL SEIZURES" This project gave me immense opportunities to...